Previous Close | 200.06 |
Open | 202.04 |
Bid | 203.95 x 1100 |
Ask | 209.18 x 800 |
Day's Range | 199.93 - 205.05 |
52 Week Range | 193.34 - 281.16 |
Volume | |
Avg. Volume | 1,431,717 |
Market Cap | 77.306B |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | 38.87 |
EPS (TTM) | 5.26 |
Earnings Date | Jul 25, 2022 - Jul 29, 2022 |
Forward Dividend & Yield | 2.78 (1.42%) |
Ex-Dividend Date | Jun 29, 2022 |
1y Target Est | 281.40 |
Subscribe to Yahoo Finance Plus to view Fair Value for SYK
Stryker (NYSE:SYK), a leading medical technologies company, attended the 6th World Intelligence Congress (WIC) in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market. This is the first time for Stryker to participate in WIC as a strategic partner in healthcare industry, marking a significant milestone for Stryker as it brings more Advanced Digital Healthcare solutions to the China market.
Microsoft, Amgen, Honeywell International, Booking Holdings and Stryker have been included in this Analyst Blog.
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.